[Webinar] Overcoming Unique Issues Regarding Trademark Searching and Filing for the Pharmaceutical Industry

April 24th, 2:00 pm ET
Rothwell, Figg, Ernst & Manbeck, P.C.
April 24th, 2024
2:00 PM ET

Trademarks in the pharmaceutical industry are important not only as part of a company’s intellectual property portfolio, but also as a matter of public health, and obtaining a trademark registration in the pharmaceutical industry raises unique issues and considerations that need to be carefully navigated. When selecting a new product name, formulating a clearance strategy, and filing and prosecuting applications for marks, there are processes and techniques that help avoid and, if necessary, overcome roadblocks from the Food & Drug Administration (FDA) and the U.S. Patent and Trademark Office (USPTO). Join us to learn how to efficiently make your selection, obtain clearance, and acquire a trademark registration in order to protect your pharmaceutical innovation.

Our 60-minute discussion will cover:

  • Initial steps in selecting pharma marks
  • Conducting the most comprehensive search possible, including searching the Orange Book and Pharma in use databases
  • Navigating proposed marks already on file at the FDA
  • Navigating naming issues at the FDA
  • Properly describing your trademark application for a new pharma product
  • Overcoming initial USPTO refusals to a pharma mark
  • Addressing possible challenges from third parties during publication
  • Unique issues with filing proof of use at the USPTO
  • AI issues that are cropping up with pharma marks


Leo Loughlin | Member | Rothwell Figg

Davide Schiavetti | Associate | Rothwell Figg

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Rothwell, Figg, Ernst & Manbeck, P.C. | Attorney Advertising


Rothwell, Figg, Ernst & Manbeck, P.C.

Rothwell, Figg, Ernst & Manbeck, P.C. on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide